Breakthrough antibody treatment suppresses HIV without antivirals
Can't see this email? View it online
   
  April 24, 2019  
  HIV/AIDS  
  The latest HIV/AIDS news from News Medical  
 Breakthrough antibody treatment suppresses HIV without antiviralsBreakthrough antibody treatment suppresses HIV without antivirals
 
A new research paper describes how an antibody that prevents HIV binding to human immune cells was shown to be able to suppress levels of HIV for up to four months.
 
   New all-in-one immunotherapy approach kicks out hiding HIV and also kills itNew all-in-one immunotherapy approach kicks out hiding HIV and also kills it
 
In a first on the quest to cure HIV, University of Pittsburgh Graduate School of Public Health scientists report today in EBioMedicine that they've developed an all-in-one immunotherapy approach that not only kicks HIV out of hiding in the immune system, but also kills it.
 
   HPV vaccination rates are low, especially in HIV prone populationsHPV vaccination rates are low, especially in HIV prone populations
 
HPV vaccination rates in populations at high-risk of contracting HIV are particularly low, increasing the risk of HPV and HIV co-infection.
 
 Johns Hopkins surgeons perform first-ever living donor HIV-to-HIV kidney transplant
 
Johns Hopkins surgeons perform first-ever living donor HIV-to-HIV kidney transplantFor the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV. A multidisciplinary team from Johns Hopkins Medicine completed the living donor HIV-to-HIV kidney transplant on Mar. 25. The doctors say both the donor and the recipient are doing well.
 
 
 C-Path and CDISC release global Therapeutic Area Standard for HIV research
 
C-Path and CDISC release global Therapeutic Area Standard for HIV researchThe Critical Path Institute and CDISC are pleased to announce the release of a global Therapeutic Area Standard that specifies how to structure commonly collected data and outcome measurements in clinical trials for HIV.
 
 
 Gut microbiome may drive HIV transmission risk in high-risk men
 
Gut microbiome may drive HIV transmission risk in high-risk menGut microbes from high HIV-risk men who have sex with men drive immune activation in mice and HIV infection in cells, according to a study published April 4 in the open-access journal PLOS Pathogens by Brent Palmer and Catherine Lozupone of the University of Colorado Anschutz, and colleagues.
 
 
 Depression symptoms associated with death among patients with HIV infection
 
Depression symptoms associated with death among patients with HIV infectionIn a new study to investigate the relationship among depressive disorders or symptoms, HIV status and mortality, researchers report that symptoms of depression are moderately associated with death among Veterans with HIV but not among those without HIV infection.
 
 
 Increased neutrophil lifespan may contribute to intestinal inflammation in HIV-infected individuals
 
Increased neutrophil lifespan may contribute to intestinal inflammation in HIV-infected individualsThe increased survival of white blood cells called neutrophils is associated with alterations in the intestinal microbiome of HIV-infected individuals, according to a study published April 11 in the open-access journal PLOS Pathogens by Nichole Klatt of the University of Miami, and colleagues.
 
 
 Rate of HPV infection high among sexual minority men despite availability of vaccine
 
Rate of HPV infection high among sexual minority men despite availability of vaccineThe rate of human papillomavirus infection is high among young minority gay, bisexual, and other men who have sex with men despite the availability of a vaccine that can prevent the infection, a Rutgers School of Public Health study found.